Wheatley D
Postgrad Med J. 1985 Sep;61(719):785-9. doi: 10.1136/pgmj.61.719.785.
Diltiazem was compared to atenolol in a double-blind trial involving 78 patients suffering from coronary heart disease. Following a 2 week control period, patients were randomly allocated to 6 weeks treatment with one or the other drug. The patients themselves made daily records of anginal attacks, trinitrate requirements, well-being and exercise tolerance. With both drugs there were highly significant reductions in the anginal attack rate and trinitrate requirements, and significant improvement on the other measures. However, there were no significant between drug differences. The incidence of side effects with diltiazem was very low and no patient had to omit treatment for this reason, although three patients did so on atenolol.
在一项涉及78名冠心病患者的双盲试验中,将地尔硫䓬与阿替洛尔进行了比较。在为期2周的对照期之后,患者被随机分配接受其中一种药物为期6周的治疗。患者自行每天记录心绞痛发作情况、硝酸酯类药物的使用需求、健康状况和运动耐量。两种药物治疗后,心绞痛发作率和硝酸酯类药物的使用需求均显著降低,其他各项指标也有显著改善。然而,两种药物之间没有显著差异。地尔硫䓬的副作用发生率非常低,没有患者因此而不得不中断治疗,尽管有3名使用阿替洛尔的患者不得不中断治疗。